Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer

Significant advancements have been made in recent years in advanced breast cancer and nearly all of them have been in the field of targeted therapy. Pertuzumab and trastuzumab-emtansine (T-DM1) have been able to be introduced in HER2-positive breast cancer. Now other anti-HER2 therapies are being de...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Geburtshilfe Frauenheilkd
Главные авторы: Welslau, Manfred, Hartkopf, Andreas D., Müller, Volkmar, Wöckel, Achim, Lux, Michael P., Janni, Wolfgang, Ettl, Johannes, Lüftner, Diana, Belleville, Erik, Schütz, Florian, Fasching, Peter A., Kolberg, Hans-Christian, Nabieva, Naiba, Overkamp, Friedrich, Taran, Florin-Andrei, Brucker, Sara Y., Wallwiener, Markus, Tesch, Hans, Schneeweiss, Andreas, Fehm, Tanja N.
Формат: Artigo
Язык:Inglês
Опубликовано: Georg Thieme Verlag KG 2019
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6805215/
https://ncbi.nlm.nih.gov/pubmed/31656319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-1001-9952
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы